CoreWeave (NASDAQ: CRWV) officer reports trust stock sales under Rule 10b5-1
Rhea-AI Filing Summary
CoreWeave, Inc. Chief Development Officer McBee Brannin reported a series of indirect transactions in CoreWeave Class A and Class B common stock on January 5, 2026, all through affiliated entities. Class B shares held by the Canis Major 2025 Family Trust LLC, the Canis Minor 2025 Family Trust LLC, and the Canis Major 2025 GRAT were converted into Class A shares on a one-for-one basis, and the resulting Class A shares were then sold in multiple trades.
The Canis Major 2025 Family Trust LLC and Canis Minor 2025 Family Trust LLC, for which Brannin serves as manager, each converted 1,000 Class B shares into Class A, then executed sales of Class A shares at weighted average prices including $77.5278, $78.2255, $79.6291, $80.5659, $81.5974, and $82.84, with price ranges from $76.82 up to $82.86.
The Canis Major 2025 GRAT, of which Brannin is sole trustee and beneficiary, converted 25,000 Class B shares into Class A and sold Class A shares at weighted average prices such as $77.4704, $78.1815, $79.263, $80.3142, $81.1536, $82.2566, $83.3962, and $84.0441, across ranges from $76.82 to $84.27. The filing notes that these sales were made under a Rule 10b5-1 trading plan adopted on September 2, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 1,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 1,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 25,000 | $0.00 | -- |
| Conversion | Class A Common Stock | 1,000 | $0.00 | -- |
| Sale | Class A Common Stock | 255 | $77.5278 | $20K |
| Sale | Class A Common Stock | 236 | $78.2255 | $18K |
| Sale | Class A Common Stock | 127 | $79.6291 | $10K |
| Sale | Class A Common Stock | 273 | $80.5659 | $22K |
| Sale | Class A Common Stock | 73 | $81.5974 | $6K |
| Sale | Class A Common Stock | 36 | $82.84 | $3K |
| Conversion | Class A Common Stock | 1,000 | $0.00 | -- |
| Sale | Class A Common Stock | 255 | $77.5284 | $20K |
| Sale | Class A Common Stock | 236 | $78.2258 | $18K |
| Sale | Class A Common Stock | 127 | $79.6311 | $10K |
| Sale | Class A Common Stock | 273 | $80.5665 | $22K |
| Sale | Class A Common Stock | 73 | $81.6008 | $6K |
| Sale | Class A Common Stock | 36 | $82.84 | $3K |
| Conversion | Class A Common Stock | 25,000 | $0.00 | -- |
| Sale | Class A Common Stock | 5,565 | $77.4704 | $431K |
| Sale | Class A Common Stock | 6,256 | $78.1815 | $489K |
| Sale | Class A Common Stock | 2,394 | $79.263 | $190K |
| Sale | Class A Common Stock | 6,065 | $80.3142 | $487K |
| Sale | Class A Common Stock | 3,451 | $81.1536 | $280K |
| Sale | Class A Common Stock | 866 | $82.2566 | $71K |
| Sale | Class A Common Stock | 295 | $83.3962 | $25K |
| Sale | Class A Common Stock | 108 | $84.0441 | $9K |
Footnotes (1)
- Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.82 to $77.75, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.83 to $78.69, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.12 to $80.06, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.12 to $81.11, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.25 to $82.02, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.82 to $82.86, inclusive. The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager. The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.82 to $77.81, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.82 to $78.81, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.82 to $79.81, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.82 to $80.80, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.82 to $81.80, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.84 to $82.78, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.88 to $83.86, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.94 to $84.27, inclusive.
FAQ
What insider activity did CoreWeave (CRWV) disclose in this Form 4?
The Form 4 reports that Chief Development Officer McBee Brannin had indirect transactions in CoreWeave Class A and Class B common stock on January 5, 2026 through three affiliated entities, involving conversions of Class B into Class A shares and subsequent sales of Class A shares.
Were the CoreWeave (CRWV) insider sales made under a Rule 10b5-1 plan?
Yes. A footnote explains that the reported sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.